Co-founder and Managing Director
Co-founder and Senior Advisor
Aaron is involved in all facets of the investment process and draws from a broad background in healthcare and start-up operations to advise and support companies throughout their growth. Aaron currently serves on the Board of Directors for Daktari Diagnostics, Pelvalon, Podimetrics, Soffio Medical and Vaxess Technologies. Previously, he served on the board of Intelligent Bio-systems (acquired by Qiagen) and was actively involved in Rhythmia Medical (acquired by Boston Scientific). As the Managing Director, Aaron is responsible for the day-to-day activities of the firm.
Prior to co-founding Norwich Ventures, Aaron worked for DEKA, the engineering think tank of Dean Kamen, where he helped develop partnerships and formulate business plans for emerging technologies. Aaron has also worked in start-up operations where he helped launch a subsidiary of Express Scripts and helped launch a venture-backed payments company. Both companies were acquired in transactions totaling over $500 million. Aaron began his career as a consultant at McKinsey & Company, where he advised healthcare clients ranging from leading medical device companies to a rural hospital system. In other healthcare related activities, Aaron serves as a board member of MassMEDIC.
Aaron earned an MBA from Harvard Business School and graduated summa cum laude from Dartmouth College with a double A.B. in Chemistry and Economics.
During graduate school, Aaron was a Teaching Fellow for introductory micro- and macro-economics at Harvard University and was awarded the Allyn Young Teaching Prize at the end of the year. The experience sparked a life-long passion for education and teaching. These days he can be seen guest lecturing on medical technology, innovation, and finance at MIT, Stanford and Harvard. Aaron is also co-author of How the Wise Decide, a book on decision-making in business (Crown Business, 2008), which has been translated into 11 foreign languages.